|
Summary Information: CytomX Therapeutics Inc. Common Stock NASDAQ:CTMX |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: CytomX is a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies. CytomX is developing a novel class of investigational conditionally activated antibody therapeutics, based on its Probody® technology platform, for the treatment of cancer. CytomX has strategic drug discovery and development collaborations with AbbVie, Amgen, Astellas, and Bristol Myers Squibb.
__The following are links to various summary and news pages for __CytomX Therapeutics Inc. Common Stock [ CTMX ]. __Note: Some Links might not have information for the company. |
|